Accuracy of PC-80B for Chest Use in Cardiac Monitoring
The PC-80B is not designed or validated for chest placement and should not be used on the chest for cardiac monitoring as this placement is not supported by clinical guidelines or device specifications.
Understanding the PC-80B Device
The PC-80B is a handheld ECG monitor that is designed for fingertip use, not chest placement. It belongs to a category of consumer wearable heart rate devices that typically use photoplethysmography (PPG) or single-lead ECG technology to detect heart rhythm.
Proper Use vs. Chest Placement
The American Heart Association (AHA) guidelines emphasize that cardiac monitoring devices should be used according to their validated placement locations 1. Consumer wearable devices are typically validated for specific body locations:
- Wrist-worn devices (like smartwatches) are designed for the wrist
- Finger-based devices (like the PC-80B) are designed for fingertip measurements
- Chest strap devices are specifically designed for chest placement
Using a device in a non-validated position can lead to:
- Inaccurate readings
- False positives/negatives
- Missed critical cardiac events
Limitations of Non-Chest-Designed Devices
When devices not designed for chest use are placed on the chest, several issues arise:
Signal Quality Problems: The PC-80B uses technology optimized for fingertip measurements. On the chest, it would encounter:
- Different tissue density and blood flow patterns
- Motion artifacts from respiration
- Interference from chest muscle activity 1
Validation Concerns: According to expert recommendations, heart rate devices must be validated for their specific placement location 1. The PC-80B has not undergone validation studies for chest placement.
Potential for Missed Events: The AHA guidelines emphasize that proper electrode placement is critical for accurate cardiac monitoring 1. Improper placement or using devices in unintended locations can miss life-threatening arrhythmias.
Appropriate Alternatives for Chest Monitoring
If chest-based cardiac monitoring is needed, the following validated options should be considered:
Standard ECG Monitoring: Traditional 12-lead ECG remains the gold standard for cardiac assessment 1
Insertable/Implantable Monitors: For long-term monitoring, devices like the Reveal LINQ system are specifically designed and validated for chest placement 1
Dedicated Chest Monitors: Purpose-built external chest monitors with proper electrode placement as recommended by AHA guidelines 1
Risks of Using Unvalidated Placement
Using the PC-80B on the chest carries several risks:
- False Reassurance: Inaccurate readings might suggest normal cardiac function when dangerous arrhythmias are present
- Missed Diagnosis: Critical cardiac events might not be detected due to suboptimal signal acquisition
- Delayed Treatment: Reliance on inaccurate data could delay necessary medical intervention
Conclusion
The PC-80B should only be used as directed by the manufacturer - typically for fingertip measurements. For proper cardiac monitoring via the chest, clinically validated devices specifically designed for chest placement should be used instead. Using the device in an unvalidated manner could lead to inaccurate readings and potentially dangerous missed diagnoses.